![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessFeasibility of risk assessment for breast cancer molecular subtypes
Few breast cancer risk assessment models account for the risk profiles of different tumor subtypes. This study evaluated whether a subtype-specific approach improves discrimination.
-
Article
Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon’s practice in a large US Academic Center
This study evaluated the impact of mainstreamed genetic testing (MGT) on the timing and uptake of testing in an academic breast surgeon’s practice. Before September 2019 (pre-MGT phase), a breast surgery pract...
-
Article
Familial pancreatic cancer: who should be considered for genetic testing?
Determining how many female patients who underwent breast imaging meet the eligibility criteria for genetic testing for familial pancreatic cancer (FPC).
-
Article
Penetrance of male breast cancer susceptibility genes: a systematic review
Several male breast cancer (MBC) susceptibility genes have been identified, but the MBC risk for individuals with a pathogenic variant in each of these genes (i.e., penetrance) remains unclear. We conducted a ...
-
Article
Management and outcomes of men diagnosed with primary breast cancer
Fewer than 1% of all breast cancers occur in men. As a result, a distinct lack of data exists regarding the management and outcomes in this cohort.
-
Article
Open AccessPerformance of a novel protease-activated fluorescent imaging system for intraoperative detection of residual breast cancer during breast conserving surgery
Safe breast cancer lumpectomies require microscopically clear margins. Real-time margin assessment options are limited, and 20–40% of lumpectomies have positive margins requiring re-excision. The LUM Imaging S...
-
Article
Disease spectrum of gastric cancer susceptibility genes
Pathogenic variants in germline cancer susceptibility genes can increase the risk of a large number of diseases. Our study aims to assess the disease spectrum of gastric cancer susceptibility genes and to deve...
-
Article
Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties
Bilateral reduction mammoplasty is one of the most common plastic surgery procedures performed in the U.S. This study examines the incidence, management, and prognosis of incidental breast cancer identified in...
-
Article
Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?
Atypical ductal hyperplasia (ADH) significantly increases the risk of breast cancer in women. However, little is known about the implications of ADH in men.
-
Article
Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions
Mammoplasty removes random samples of breast tissue from asymptomatic women providing a unique method for evaluating background prevalence of breast pathology in normal population. Our goal was to identify the...
-
Article
A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations
The rapid drop in the cost of DNA sequencing led to the availability of multi-gene panels, which test 25 or more cancer susceptibility genes for a low cost. Clinicians and genetic counselors need a tool to int...
-
Chapter
Breast Cancer Risk Prediction in Women with Atypical Breast Lesions
Women with atypical breast lesions have a markedly increased risk of develo** breast cancer. The risk of breast cancer in women with lobular carcinoma in situ is seven- to nine-fold that of the general popul...
-
Article
Reassessing risk models for atypical hyperplasia: age may not matter
The aim of this study was to investigate the influence of age at diagnosis of atypical hyperplasia (“atypia”, ductal [ADH], lobular [ALH], or severe ADH) on the risk of develo** subsequent invasive breast ca...
-
Article
Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
-
Article
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
Numerous models have been developed to quantify the combined effect of various risk factors to predict either risk of develo** breast cancer, risk of carrying a high-risk germline genetic mutation, specifica...
-
Article
Using machine learning to parse breast pathology reports
Extracting information from electronic medical record is a time-consuming and expensive process when done manually. Rule-based and machine learning techniques are two approaches to solving this problem. In th...
-
Chapter
Risk Assessment for Breast Cancer
Genetic testing for individuals with familial or hereditary risk for breast cancer is essential to improving prevention and survival. Identifying unaffected BRCA1/2 mutation carriers before they develop breast ca...
-
Article
DCIS does not need treatment… really?
-
Article
Doing “nothing” for DCIS: a case report
-
Article
False-negative rate of combined mammography and ultrasound for women with palpable breast masses
Mammography and ultrasound are often used concurrently for patients with palpable breast masses. While mammography has a false-negative rate of approximately 15 %, the addition of breast ultrasound decreases t...